[Primary progressive multiple sclerosis: current issues of timely diagnosis].

@article{Popova2017PrimaryPM,
  title={[Primary progressive multiple sclerosis: current issues of timely diagnosis].},
  author={Ekaterina Valerievna Popova and A. N. Boyko and M. A. Barabanova and L. N. Antipova and K. Z. Bakhtiyarova and Anna N. Belova and V S Solovieva and G. N. Belskaya and I. G. Lukashevich and L I Nikolaeva and L. I. Volkova and E. L. Turova and A V Kraeva and Zoya Alexandrovna Goncharova and N. A. Malkova and Irina E. Poverennova and Stella Sivertseva and A. V. Zhelnin and T N Trushnikova and F. A. Khabirov and T. I. Khaibullin},
  journal={Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova},
  year={2017},
  volume={117 10. Vyp. 2},
  pages={
          35-40
        }
}
This article presents a review of international data on primary progressive multiple sclerosis (PPMS) and an analysis of factors influencing timely diagnosis of PPMS in a number of regions of the Russian Federation. 
3 Citations

[Primary-progressive multiple sclerosis in Russia: a medical-sociological study involving patients and neurologists].

The study revealed typical medical and social problems patients with PPMS faced and a significant decrease in quality-of-life of PPMS patients was shown.

The quality of artificial intelligence algorithms for identifying manifestations of multiple sclerosis on magnetic resonance imaging (systematic review)

The relatively high values obtained for the main measures were offset by the methodological errors when creating the baseline data sets, and lack of validation using independent data, which indicate that automatic identification of multiple sclerosis manifestations on magnetic resonance imaging may be achievable.

Радиологически изолированный синдром – МРТ критерии и тактика ведения

ЖУРНАЛ НЕВРОЛОГИИ И ПСИХИАТРИИ, 8, 2018; Вып. 2 Рассеянный склероз (РС) в настоящее время рассматривается как иммунологически опосредованное демиелинизирующее и нейродегенеративное заболевание ЦНС,

References

SHOWING 1-10 OF 28 REFERENCES

Defining the clinical course of multiple sclerosis: The 2013 revisions

It is clear that pathophysiology should take precedence over clinical and subjective descriptions when defining disease subtypes, and the subtypes proposed by Lublin et al. are arbitrary and often diagnosed retrospectively.

Natural history of primary progressive multiple sclerosis

  • G. Ebers
  • Psychology, Medicine
    Multiple sclerosis
  • 2004
Natural history data from a population-based cohort of patients with PPMS followed for approximately 25 years demonstrate remarkable similarities in the progressive phases of PPMS and SPMS, and the evidence that PPMS is distinct remains weak.

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

These revisions simplify the McDonald Criteria, preserve their diagnostic sensitivity and specificity, address their applicability across populations, and may allow earlier diagnosis and more uniform and widespread use.

Primary progressive multiple sclerosis

  • X. Montalban
  • Medicine, Psychology
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
  • 2001
Purpose of reviewThe present article reviews the currently ongoing scientific debate on the specific characteristics of primary progressive multiple sclerosis. Recent findingsThe most important

The natural history of primary progressive MS in British Columbia, Canada

Background: Primary progressive multiple sclerosis (PPMS) has a distinct clinical phenotype and has historically been understudied with few longitudinal natural history studies spanning a reasonable

A significant decrease in diagnosis of primary progressive multiple sclerosis: A cohort study

The diagnosis of PPMS has significantly decreased in Sweden specifically after introduction of disease-modifying treatments, and the current trend to emphasise presence or absence of inflammatory activity is already reflected in clinical practice.

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

The revised criteria facilitate the diagnosis of MS in patients with a variety of presentations, including “monosymptomatic” disease suggestive of MS, disease with a typical relapsing‐remitting course, and disease with insidious progression, without clear attacks and remissions.

New diagnostic criteria for multiple sclerosis: Guidelines for research protocols

Today there is a need for more exact criteria than existed earlier in order to conduct therapeutic trials in multicenter programs, to compare epidemiological surveys, to evaluate new diagnostic procedures, and to estimate the activity of the disease process in MS.

Multiple sclerosis diagnostic criteria: three years later

The purpose of the current review is to present and evaluate the key studies that have been performed using the McDonald criteria since 2001 and to set the stage for an upcoming re-evaluation of the new criteria based on data-driven information gathered since their development.

Diagnostic criteria for multiple sclerosis